Subscribe to our RSS feeds RSS | Login | Register  
 

 Marketing & Communications Articles

Rx drug word-of-mouth occurs largely offline: study

Ben Comer July 11, 2008

Consumers engaging in prescription drug-related word-of-mouth tend to do it offline, according to a Keller Fay Group report.
 

PhRMA Code cracks down on gifts to docs

Matthew Arnold July 10, 2008

PhRMA revised its Code on Interactions with Healthcare Professionals to sharply limit gifts to physicians.
 

Pfizer sacks commercial support of CME

Matthew Arnold July 02, 2008

Pfizer will no longer fund continuing medical education through med ed firms.
 

Fed up Sermo docs draft manifesto

Matthew Arnold July 01, 2008

A physicians' manifesto of sorts, composed by Sermo doctors demanding an end to intrusive insurers and overzealous regulators, has garnered 5,200 signatures in the several weeks since it was posted.
 

Sudler & Hennessey appoints Co-CEOs

Ben Comer June 30, 2008

Rob Rogers and Louisa Holland have been promoted to co-CEO of Sudler and Hennessey's operations in the Americas.
 

AMA CME measure goes nowhere

Matthew Arnold June 16, 2008

A proposal by the American Medical Association's Council on Ethical and Judicial Affairs (CEJA) calling for the elimination of commercial sponsorship of medical education was referred back to the council, effectively tabling it for the year.
 

First-year sales of GSK's Alli 'underwhelming,' analyst says

Stephen McGuire June 12, 2008

Although four million people have tried GlaxoSmithKline's OTC weight loss drug Alli during its first year on the market, preliminary sales figures are "pretty underwhelming," one analyst tells the Associated Press.
 

Prevention survey: pols' bluster doesn't dent DTC

Matthew Arnold June 10, 2008

All the fury over DTC drug ads emanating from Washington hasn't dented their credibility with consumers, according to Rodale's 11th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs.
 

Merck agrees to pre-approval of TV ads in Vioxx settlement

Matthew Arnold May 22, 2008

Merck has agreed to submit all TV ads to the FDA before running them and to adhere to agency recommendations on them as part of a Vioxx-related settlement.
 

FDA warns Shire on Fosrenol marketing materials

Stephen McGuire May 12, 2008

Shire received a warning letter from the FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) asking the drugmaker to halt distribution of specific professional marketing materials for its end stage renal disease treatment Fosrenol (lanthanum carbonate).